Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Astellas Pharma launches Myrbetriq in U.S.

Oct. 23, 2012

Mirabegron recommended for European approval

Oct. 22, 2012

New data on onabotulinumtoxinA reveals benefits on patient-reported outcomes

Oct. 22, 2012

Ono Pharmaceutical designs novel E-NPP 2 inhibitors

Oct. 22, 2012

NEPTUNE I and II data on tamsulosin/solifenacin presented

Oct. 22, 2012

Phase II and III studies of bardoxolone methyl suspended

Oct. 19, 2012

Researchers describe activity of TAC-302

Oct. 19, 2012

Mitsubishi Tanabe and Kureha complete EPPIC phase III studies

Oct. 10, 2012

Encouraging follow-up data emerges from phase IIb PRX-302 study

Oct. 10, 2012

AstraZeneca and Ardelyx sign licensing deal for NHE-3 inhibitor program

Oct. 10, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...